FDA.reportPublic FDA data

etelcalcetide 5 MG in 1 ML Injection

RxCUI
1876135
RxNorm name
etelcalcetide 5 MG in 1 ML Injection
Display name
etelcalcetide 5 MG in 1 ML Injection
Full name
etelcalcetide 5 MG in 1 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PARSABIVETELCALCETIDEAmgen, Inccd270093-c6a8-4596-a4ab-e6aa0a2c8a0c2026-03-08Warnings, Adverse reactionsExact identifier
rxcui: 1876135

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cd270093-c6a8-4596-a4ab-e6aa0a2c8a0cetelcalcetide 5 MG in 1 ML Injection [PSN] · 1 ML etelcalcetide 5 MG/ML Injection [SCD] · etelcalcetide 5 MG per 1 ML Injection [SY]315These highlights do not include all the information needed to use PARSABIV safely and effectively. See full prescribing information for PARSABIV. PARSABIV ® (etelcalcetide) injection, for intravenous use Initial U.S. Approval: 201720260308